WO2002081747A1 - Procede de test de sensibilite aux steroides - Google Patents
Procede de test de sensibilite aux steroides Download PDFInfo
- Publication number
- WO2002081747A1 WO2002081747A1 PCT/JP2002/001917 JP0201917W WO02081747A1 WO 2002081747 A1 WO2002081747 A1 WO 2002081747A1 JP 0201917 W JP0201917 W JP 0201917W WO 02081747 A1 WO02081747 A1 WO 02081747A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- steroid
- examining
- genes
- responsiveness
- steroid responsiveness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70539—MHC-molecules, e.g. HLA-molecules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/474,079 US20040197786A1 (en) | 2001-04-05 | 2002-03-01 | Method of examining steroid resnponsiveness |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-107557 | 2001-04-05 | ||
| JP2001107557A JP2002300883A (ja) | 2001-04-05 | 2001-04-05 | ステロイド応答性の検査方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002081747A1 true WO2002081747A1 (fr) | 2002-10-17 |
Family
ID=18959862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2002/001917 Ceased WO2002081747A1 (fr) | 2001-04-05 | 2002-03-01 | Procede de test de sensibilite aux steroides |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20040197786A1 (ja) |
| JP (1) | JP2002300883A (ja) |
| WO (1) | WO2002081747A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076666A1 (ja) * | 2003-02-28 | 2004-09-10 | Toshihiko Shiroishi | ガスダーミンファミリー |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| AU2007309726A1 (en) * | 2006-04-07 | 2008-05-02 | Xdx, Inc. | Steroid responsive nucleic acid expression and prediction of disease activity |
| WO2008021431A2 (en) | 2006-08-14 | 2008-02-21 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders |
| US8148067B2 (en) | 2006-11-09 | 2012-04-03 | Xdx, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| JP2009092508A (ja) * | 2007-10-09 | 2009-04-30 | Norihiro Nishimoto | リウマチ治療剤の効果の予測方法 |
| EP2220489B1 (en) * | 2007-12-14 | 2015-02-18 | Index Pharmaceuticals AB | Method for predicting re-sensitization to steroid therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985547A (en) * | 1994-03-04 | 1999-11-16 | Children's Hospital Of Philadelphia | Detection of a mutation in the HLA-DMβ gene in an immunocompromised patient |
| US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
| US20010034023A1 (en) * | 1999-04-26 | 2001-10-25 | Stanton Vincent P. | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
| US20030154032A1 (en) * | 2000-12-15 | 2003-08-14 | Pittman Debra D. | Methods and compositions for diagnosing and treating rheumatoid arthritis |
| US6905827B2 (en) * | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
-
2001
- 2001-04-05 JP JP2001107557A patent/JP2002300883A/ja active Pending
-
2002
- 2002-03-01 WO PCT/JP2002/001917 patent/WO2002081747A1/ja not_active Ceased
- 2002-03-01 US US10/474,079 patent/US20040197786A1/en not_active Abandoned
Non-Patent Citations (3)
| Title |
|---|
| KELLY A.P. ET AL.: "A new human HLA class II-related locus, DM", NATURE, vol. 353, no. 6344, 10 October 1991 (1991-10-10), pages 571 - 573, XP002952631 * |
| POPOVICI R.M. ET AL.: "Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology", ENDOCRINOLOGY, vol. 141, no. 9, 2000, pages 3510 - 3513, XP002952633 * |
| SHAMAN J. ET AL.: "Analysis of HLA-DMB mutants and -DMB genomic structure", IMMUNOGENETICS, vol. 41, 1995, pages 117 - 124, XP002952632 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076666A1 (ja) * | 2003-02-28 | 2004-09-10 | Toshihiko Shiroishi | ガスダーミンファミリー |
Also Published As
| Publication number | Publication date |
|---|---|
| US20040197786A1 (en) | 2004-10-07 |
| JP2002300883A (ja) | 2002-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bry et al. | A model of host-microbial interactions in an open mammalian ecosystem | |
| EP2343083A3 (en) | Method of selecting patients suitable for WT1 vaccine | |
| WO1997012992A3 (en) | Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore | |
| CA2465800A1 (en) | Instrument | |
| WO2005029067A3 (en) | Method of diagnosing breast cancer | |
| WO2001057274A8 (en) | Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart | |
| AU2003281336A1 (en) | Compositions and methods for the detection of human t cell receptor variable family gene expression | |
| AU5479599A (en) | Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes | |
| EP1721992A3 (en) | Methods and nucleic acids for analyses of cellular proliferative disorders | |
| WO2002048310A3 (en) | Methods and compositions for diagnosing and treating rheumatoid arthritis | |
| WO2002040634A3 (en) | Expression miniarrays and uses thereof | |
| IL147349A0 (en) | Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles | |
| WO2002081747A1 (fr) | Procede de test de sensibilite aux steroides | |
| EP2339348A3 (en) | Method for diagnosing neuro-degenerative disease | |
| EP3792362A8 (en) | Method and kit for identifying state of colorectal cancer | |
| WO2006021519A3 (en) | Integrated device for diagnostic analyses, and relative method | |
| MXPA01011182A (es) | Metodos, composiciones y conjuntos para indicador biologico de esterilizacion. | |
| CA2531451A1 (en) | Methods and nucleic acids for analyses of colorectal cell proliferative disorders | |
| BRPI0001536B8 (ja) | ||
| WO2002071064A1 (en) | Method of examining steroid-responsiveness | |
| CA2406443A1 (en) | Method for quantification of akt protein expression | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
| WO2004009843A3 (de) | Nachweis von mikroorganismen | |
| WO2001049879A3 (en) | Methods for comparing gene expression levels or patterns in normal or tumor cells | |
| WO2005005957A3 (en) | Method of detecting cancer using delta-catenin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA KR US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 10474079 Country of ref document: US |
|
| 122 | Ep: pct application non-entry in european phase |